Immediate improvement in walking, sensation, and taste after PSE treatment by Dr. Tobinick, years after multiple strokes. Filmed on June 10, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvement in central post-stroke pain, sensation, spasticity, vision, walking, and taste after PSE treatment by Dr. Tobinick, 2 years after hemorrhagic stroke. Filmed on April 8, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Rapid improvement in cervical dystonia (spasmodic torticollis) and dysarthria after PSE treatment by Dr. Tobinick, 4.5 years after traumatic brain injury and hemorrhagic stroke. Filmed on May 20, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Rapid improvement in post-stroke pain, spasticity, walking, and sensation after PSE treatment by Dr. Tobinick, 1 year after stroke. Filmed on April 29, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvement in speech, post-stroke pain, left neglect, sensation, and spasticity after PSE treatment by Dr. Tobinick, 1.5 years after stroke. Filmed on March 18, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0